Skip to main content
SpringerLink
Log in

Move for more Medicare off-label cancer drugs creates contention

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Bristol N.Medicare drug expansion causes controvery in the USA. Lancet 373: 532, No. 9663, 14 Feb 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Move for more Medicare off-label cancer drugs creates contention. Pharmacoecon. Outcomes News 572, 2 (2009). https://doi.org/10.2165/00151234-200905720-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905720-00002

Keywords

Search

Navigation